Navigation Links
Hypertension drugs could lower Disability

According to reseasrches, drugs used to treat hypertension could delay muscle loss and disability in seniors. Dr.Graziano Onder, research associate at University of Hopkins has suggested new, beneficial effects of (Angiotensin Converting Enzyme) ACE-inhibitor //drugs, which are widely used for hypertension, beneficial effects on muscle strength and overall physical performance in older adults. This research must be confirmed in future clinical trials.

The Food and Drug Administration has approved such ACE inhibitors as Accupril, Captopril, Altace and Vasotec. The retrospective study at Hokins, published in the medical journal The Lancet, involved analysis of three years of data from 1995 to 1999 on 650 hypertensive and partially disabled women over 60 who participated in the Women's Health and Aging Study, a project of the National Institute on Aging in Bethesda, Md.

The women on continuous ACE inhibitor therapy showed slower loss of walking speed and muscle strength compared to those using other hypertension drugs or using none. During repeated testing over the three-year period, the subjects walking speeds were measured and they were graded on muscle strength.

Correlating that data to pharmaceutical records, the researchers found women on continuous ACE inhibitor therapy had a lower average decline in muscle strength of 2.5 pounds over the three years, as compared to intermittent users of other antihypertensive drugs, at 7.5 pounds and non-users at minus 8.1 pounds.

Continuous ACE inhibitor users had a smaller loss in walking speed -- sixth-tenths of an inch per second compared with intermittent users of ACE inhibitors at 5.3 inches per second, 6.1 inches per second for intermittent users of other antihypertensive drugs and 7 inches per second for non-users.

"If these findings can be confirmed in randomized controlled trials, ACE inhibitors could not only be used as first-line treatment of older adults with h
'"/>




Page: 1 2

Related medicine news :

1. New viewpoint on Hypertension
2. FDA Approves Remodulin for Pulmonary Hypertension
3. Glaucoma & Ocular Hypertension more likely in patients with refractive errors
4. Hypertension lowered by Bedtime Dosing
5. Better Treatment For Hypertension
6. Treating Pulmonary Arterial Hypertension In Children With Viagra
7. Hypertension Drug of Choice for African Americans
8. Hypertension can be caused by Inhalation of Salt
9. Inhaling Salt Can Lead To Hypertension
10. Elderly Women Remain At Risk From Hypertension
11. Elderly Women Remain At Risk From Hypertension
Post Your Comments:
(Date:3/18/2010)... Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... ... WASHINGTON , March 18 Kids in New Jersey will take center stage in the fight against tobacco on March ...
(Date:3/18/2010)... ... , , ... ... ... New Hampshire will take center stage in the fight against tobacco on March 24 as they join thousands of young people nationwide ...
(Date:3/18/2010)... President and CEO, Legacy(SM) , ... , , ... ... WASHINGTON , March ... ...
(Date:3/18/2010)... of U.S. medical students choosing internal medicine residencies ... significantly impact the shortage of primary care physicians. ... Program report, 2,722 U.S. seniors at medical schools ... 3.4 percent increase from 2,632 in 2009. The ... (2,660), 2007 (2,680), and 2006 (2,668). In comparison, ...
(Date:3/18/2010)... In its 21-year history, under the ... leaders, SRLA has trained more than 40,000 teenagers from ... area to complete the 26.2 mile Los Angeles Marathon. ... volunteer leaders will again participate in the LA Marathon. ... SRLA,s mission is to challenge at-risk secondary students to ...
Breaking Medicine News(10 mins):Health News:New Jersey Kids 'Kick Butts' on March 24 2Health News:New Jersey Kids 'Kick Butts' on March 24 3Health News:New Jersey Kids 'Kick Butts' on March 24 4Health News:New Jersey Kids 'Kick Butts' on March 24 5Health News:New Hampshire Kids 'Kick Butts' on March 24 2Health News:New Hampshire Kids 'Kick Butts' on March 24 3Health News:New Hampshire Kids 'Kick Butts' on March 24 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 2Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 3Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 5Health News:Residency match results not encouraging for adults needing primary care 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 3
... study finds that offenders' lack of trust in medical ... they are experiencing mental distress.// ,Men who ... illness and suicide and under-utilise mental health services compared ... positive prior encounter with a health professional may predict ...
... at the University of Pennsylvania School of Medicine have ... for patients who suffer from high cholesterol// levels. ... the New England Journal of Medicine (NEJM). In this ... condition refractory to conventional therapy, had a remarkable 51% ...
... the elderly tend to succumb more to respiratory infections ... Very cold weather, combined with fog, like the capital ... for certain viruses to spread that cause influenza type ... are prone to the ill effects of low temperature. ...
... were found to be deficient in nutrients or calories,// and ... deprived in the province, researchers from University of Ontario said. ... Health, examined 180 food hampers, sourced from a well established ... 99 per cent of the hampers, meant to last three ...
... prove conclusive.// , Scientists claim to have found a ... DNA found at the ends of the chromosome. ,Nilesh Samani ... journal, The Lancet, detailed their experiments on 1500 men, in the ... length of their telomere (sampled from white blood cells) found that ...
... the use of viruses like that of the common cold ... ,Leonard Seymour, a professor of gene therapy at Oxford ... viruses. ,While the technique, called virotherapy, is not new, ... tumors, which have spread, or in essence cancer cells, which ...
Other Medicine News:Health News:Offenders Unlikely to Seek Help 2Health News:New Therapy to Treat Patients With Severely Elevated Cholesterol Levels 2Health News:New Therapy to Treat Patients With Severely Elevated Cholesterol Levels 3Health News:Severe Cold is Harbinger of Infections 2Health News:Humble Cold to Combat Cancer 2
(Date:3/18/2010)... March 18 Poniard Pharmaceuticals, Inc. ... innovative oncology therapies, today announced that the U.S. Patent ... the composition of matter patent for picoplatin as RE41209, ... 2010 . The reissue was applied for May ... , the USPTO released the "Issue Notification" for the ...
(Date:3/18/2010)... , March 18 ... Chief Executive Officer, Pfizer, was elected board ... of America (PhRMA) today at the trade ... Chief Executive Officer Christopher Viehbacher ... Directors, and John C. Lechleiter , ...
(Date:3/18/2010)... results in too much ammonia in the blood. , ... , , ... ... (Logo: ... ...
Breaking Medicine Technology:U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 2U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 3U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 4U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 2Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 3Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 4Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 6Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 7Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 8FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 2FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 3FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 4FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 5Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 1Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 2Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 3Exposure to lead tobacco smoke raises risk of ADHD 10856 1Exposure to lead tobacco smoke raises risk of ADHD 10856 2Measuring and modeling blood flow in malaria 61892 1Measuring and modeling blood flow in malaria 61892 2
... online today in the,New England Journal of Medicine ... candidate provides both infants and young children,with significant ... earlier study results and support the ongoing efforts, ... of GlaxoSmithKline,(NYSE: GSK ) Biologicals, RTS,S/AS ...
... Potent Activity Against Antibiotic Resistant Gram-Positive Pathogens and MRSA ... NEW HAVEN, Conn., Dec. 8 Rib-X ... focused on the discovery, development and commercialization of novel ... positive topline results from a Phase 2 clinical trial ...
Other Medicine Technology:Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa 2Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa 3Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa 4Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa 5Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa 6Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa 7Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa 8Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin 2Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin 3Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin 4
... Graft is an all-natural biologic implant derived ... prepared using the proven Tutoplast process with ... non-collagenous cellular components. It can be ... wall repair cases where a synthetic prostheses ...
... TONO-PEN AVIA tonometer is an easy-to-use, ... that correlate strongly with Goldmann tonometry. ... design and advanced electronic measurement technology ... and accurate IOP measurements with minimal ...
... first compact, mobile femtosecond surgical laser, has ... platform for a wide spectrum of applications ... the demand of refractive surgeons for an ... an efficient LASIK work-flow. The solution by ...
Bottega Venetas new collection expresses a unique style and determined personality: discreet elegance and refined luxury are the themes that inspire the creation of these new models, destined to beco...
Medicine Products: